Skip to Content

1,383 Results Found

  • Article
  • Open Access
19 Citations
5,602 Views
12 Pages

Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy

  • Nicola Iacomino,
  • Fiammetta Vanoli,
  • Rita Frangiamore,
  • Marta Ballardini and ,
  • Letizia Scandiffio,
  • Federica Bortone,
  • Francesca Andreetta,
  • Fulvio Baggi,
  • Pia Bernasconi and
  • Renato Mantegazza
  • + 7 authors+ 2 authors

The complement system plays a key role in myasthenia gravis (MG). Anti-complement drugs are emerging as effective therapies to treat anti-acetylcholine receptor (AChR) antibody-positive MG patients, though their usage is still limited by the high cos...

(This article belongs to the Special Issue Molecular Mechanisms of Neurological Autoimmune Disorders)
  • Article
  • Open Access
3 Citations
2,610 Views
12 Pages

Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients

  • Anna Sobuś,
  • Bartłomiej Baumert,
  • Monika Gołąb-Janowska,
  • Piotr Kulig and ,
  • Edyta Paczkowska,
  • Karolina Łuczkowska,
  • Dorota Rogińska,
  • Alicja Zawiślak,
  • Sławomir Milczarek and
  • Bogusław Machaliński
  • + 11 authors+ 6 authors

11 November 2021

ALS remains a fatal, neurodegenerative motor neuron disease. Numerous studies seem to confirm that innate immune system is involved in the pathophysiology of ALS. Hence, the assessment of the complement system and attempts to modify its activity rema...

(This article belongs to the Special Issue Amyotrophic Lateral Sclerosis: Latest Advances and Prospects)
  • Review
  • Open Access
23 Citations
9,277 Views
15 Pages

Complement and Complement Targeting Therapies in Glomerular Diseases

  • Sofia Andrighetto,
  • Jeremy Leventhal,
  • Gianluigi Zaza and
  • Paolo Cravedi

16 December 2019

The complement cascade is part of the innate immune system whose actions protect hosts from pathogens. Recent research shows complement involvement in a wide spectrum of renal disease pathogenesis including antibody-related glomerulopathies and non-a...

(This article belongs to the Special Issue Rare Kidney Diseases: New Translational Research Approach to Improve Diagnosis and Therapy)
  • Systematic Review
  • Open Access
3 Citations
5,724 Views
15 Pages

1 July 2025

Background/Objectives: The field of nephrology is increasingly embracing advanced treatments and clinical trials that focus on inhibiting specific components of the complement cascade, a key driver in complement-mediated kidney diseases. Materials an...

(This article belongs to the Section Urology & Nephrology)
  • Review
  • Open Access
39 Citations
6,933 Views
32 Pages

Complement in Tumourigenesis and the Response to Cancer Therapy

  • Rebecca M. O’Brien,
  • Aoife Cannon,
  • John V. Reynolds,
  • Joanne Lysaght and
  • Niamh Lynam-Lennon

10 March 2021

In recent years, our knowledge of the complement system beyond innate immunity has progressed significantly. A modern understanding is that the complement system has a multifaceted role in malignancy, impacting carcinogenesis, the acquisition of a me...

  • Review
  • Open Access
44 Citations
16,471 Views
35 Pages

Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration

  • Sarah Hammadi,
  • Nikolaos Tzoumas,
  • Mariantonia Ferrara,
  • Ingrid Porpino Meschede and ,
  • Katharina Lo,
  • Claire Harris,
  • Majlinda Lako and
  • David H. Steel
  • + 3 authors+ 0 author

14 April 2023

The complement system is crucial for immune surveillance, providing the body’s first line of defence against pathogens. However, an imbalance in its regulators can lead to inappropriate overactivation, resulting in diseases such as age-related...

(This article belongs to the Special Issue Imaging in Ophthalmology—Volume I)
  • Review
  • Open Access
9 Citations
3,185 Views
16 Pages

The Pleiotropic Effect of Complement C5a-C5aR1 Pathway in Diseases: From Immune Regulation to Targeted Therapy

  • Baohong Xu,
  • Zhi Zhou,
  • Yang Xiao,
  • Qiaolin Liu and ,
  • Tiaoyi Xiao,
  • Zhao Lv and
  • Hongquan Wang
  • + 2 authors+ 0 author

3 December 2025

The complement system plays a pivotal role in the body’s immune defense mechanism. Its key effector molecule C5a and its primary receptor C5aR1 exhibit complex “double-edged sword” effects in various disease processes, including inf...

(This article belongs to the Special Issue Advances in Pro-Inflammatory and Anti-Inflammatory Cytokines)
  • Systematic Review
  • Open Access
360 Views
40 Pages

A Systematic Review of Complement-Targeting Therapies for Geographic Atrophy: Insights into Advanced Drug Delivery Systems and Gene-Based Approaches

  • Paula Fernández-Muro,
  • Ana del Pozo-Rodríguez,
  • María Ángeles Solinís and
  • Alicia Rodríguez-Gascón

Background/Objectives: Geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD), causes irreversible central vision loss and has limited treatment options. Complement dysregulation plays a pivotal role in GA pathogenesi...

(This article belongs to the Special Issue Advanced Nanotechnology-Based Strategies for Ocular Diseases Treatment)
  • Review
  • Open Access
1,340 Views
21 Pages

The Complosome: An Emerging Intracellular Complement Network in Cancer Development and Therapy

  • Łukasz Zadroga,
  • Filip Lewandowski,
  • Dominika Bębnowska,
  • Adam Majchrzak and ,
  • Alina Czyż and
  • Paulina Niedźwiedzka-Rystwej
  • + 1 author+ 0 author

The complement system is traditionally recognized as a major effector of innate immunity, essential for pathogen clearance, inflammation and the maintenance of tissue homeostasis. In recent years, however, its role in cancer has been substantially re...

(This article belongs to the Section Molecular Immunology)
  • Review
  • Open Access
2 Citations
2,618 Views
24 Pages

24 February 2026

Glaucoma is no longer viewed solely as a pressure-mediated optic neuropathy but as a chronic neurodegenerative disease with a strong immune component. Across experimental models and patient samples, convergent inflammatory circuitry complement activa...

(This article belongs to the Special Issue Research on Glaucoma Diseases)
  • Review
  • Open Access
17 Citations
8,652 Views
26 Pages

26 April 2020

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal disease that presents an estimated incidence of 1.3 cases per million per year, with a prevalence of 15.9 cases per million. It is characterized by hemolysis, bone marrow dysfunction with per...

(This article belongs to the Section Hematology)
  • Review
  • Open Access
1 Citations
2,573 Views
35 Pages

Complement Dysregulation in Kidney Diseases: Mechanisms, Biomarkers, and Emerging Targeted Therapies

  • Patryk Jesiołowski,
  • Mateusz Krzywda,
  • Agnieszka Furmańczyk-Zawiska and
  • Magdalena Durlik

The complement system is the primary defense mechanism against pathogens, acting through opsonization, the membrane attack complex, and classical, lectin, or alternative pathways. These pathways result in the production of key complement components,...

(This article belongs to the Special Issue The Role of Complement Regulation in Kidney Disease)
  • Review
  • Open Access
22 Citations
11,530 Views
9 Pages

14 March 2018

Human application of monoclonal antibodies (mAbs), enzymes, as well as contrast media and many other particulate drugs and agents referred to as “nanomedicines”, can initiate pseudoallergic hypersensitivity reactions, also known as infusion reactions...

(This article belongs to the Special Issue Monoclonal Antibodies)
  • Review
  • Open Access
1,232 Views
15 Pages

New Insights in Diagnosis and Therapy of Paroxysmal Nocturnal Hemoglobinuria (PNH)

  • Francesco Lanza,
  • Evita Massari,
  • Barbara Castagnari,
  • Martina Cantelli and
  • Giorgio Zavagli

6 August 2026

PNH is an acquired ultrarare disease caused by a somatic mutation of PIGA gene located at band 22 of the short arm of the X chromosome, which is unable to carry out the synthesis of glycosil-phosphatidyl-inositol. The loss of complement regulators CD...

(This article belongs to the Special Issue Bone Marrow Failure and Leukemia Predisposition Syndromes)
  • Review
  • Open Access
24 Citations
7,162 Views
24 Pages

Genetic Aspects of Age-Related Macular Degeneration and Their Therapeutic Potential

  • Elisa Stradiotto,
  • Davide Allegrini,
  • Giovanni Fossati,
  • Raffaele Raimondi and ,
  • Tania Sorrentino,
  • Domenico Tripepi,
  • Gianmaria Barone,
  • Antonio Inforzato and
  • Mario R. Romano
  • + 4 authors+ 0 author

31 October 2022

Age-related macular degeneration (AMD) is a complex and multifactorial disease, resulting from the interaction of environmental and genetic factors. The continuous discovery of associations between genetic polymorphisms and AMD gives reason for the p...

(This article belongs to the Special Issue Gene and Cell Therapy for Ophthalmology Disease)
  • Article
  • Open Access
5 Citations
3,516 Views
16 Pages

Different Proteomic Profiles Regarding Antihypertensive Therapy in Preeclampsia Pregnant

  • Caroline C. Pinto-Souza,
  • Julyane N. S. Kaihara,
  • Priscila R. Nunes,
  • Moises H. Mastella and ,
  • Bruno C. Rossini,
  • Bruna Cavecci-Mendonça,
  • Ricardo de Carvalho Cavalli,
  • Lucilene D. dos Santos and
  • Valeria C. Sandrim
  • + 4 authors+ 0 author

10 August 2024

Preeclampsia (PE) is a hypertensive pregnancy syndrome associated with target organ damage and increased cardiovascular risks, necessitating antihypertensive therapy. However, approximately 40% of patients are nonresponsive to treatment, which result...

(This article belongs to the Special Issue Pregnancy Complicated by Hypertension—New Horizons in the Pathomechanism, Diagnosis, and Treatment)
  • Article
  • Open Access
5 Citations
2,689 Views
20 Pages

The Function of Transforming Growth Factor 2 in Facilitating Inflammasome Activation to Enhance the Development of Myopia via Complement System

  • Sheng-Chun Lin,
  • Yu-An Hsu,
  • Chi-Fong Lin,
  • Chih-Sheng Chen and ,
  • Peng-Tai Tien,
  • Yao-Chien Wang,
  • Ching-Yao Chang,
  • En-Shyh Lin,
  • Jamie Jiin-Yi Chen and
  • Lei Wan
  • + 7 authors+ 2 authors

20 August 2025

Myopia is one of the major public health conditions with significant complications. This study investigates the role of transforming growth factor (TGF)-β2, complement activation, and inflammasome pathways in myopia progression using a Brown Nor...

  • Systematic Review
  • Open Access
12 Citations
4,618 Views
28 Pages

Complement Inhibitors for Geographic Atrophy in Age-Related Macular Degeneration—A Systematic Review

  • Ana Maria Dascalu,
  • Catalin Cicerone Grigorescu,
  • Dragos Serban,
  • Corneliu Tudor and ,
  • Cristina Alexandrescu,
  • Daniela Stana,
  • Sanda Jurja,
  • Andreea Cristina Costea,
  • Catalin Alius and
  • Bogdan Mihai Cristea
  • + 8 authors+ 3 authors

17 September 2024

Background/Objectives: Age-related macular degeneration (AMD) is one of the main causes of blindness and visual impairment worldwide. Intravitreal complement inhibitors are an emergent approach in the treatment of AMD, which have had encouraging resu...

(This article belongs to the Special Issue Personalized Diagnosis and Therapies in Retinal Diseases)
  • Article
  • Open Access
2 Citations
3,085 Views
24 Pages

Real-World Evidence of the Disease Burden and Economic Impact of Paroxysmal Nocturnal Hemoglobinuria in Italy

  • Roberta Bini,
  • Lorena D’Anna,
  • Diletta Valsecchi,
  • Stefania Mazzoni and ,
  • Valentina Perrone and
  • Luca Degli Esposti
  • + 1 author+ 0 author

22 April 2025

Background/Objectives: This analysis was conducted in Italy to estimate the epidemiology of paroxysmal nocturnal hemoglobinuria (PNH) and to describe the features and economic burden of PHN in the adult population considering the role of anti-complem...

(This article belongs to the Section Epidemiology & Public Health)
  • Article
  • Open Access
48 Citations
9,001 Views
27 Pages

Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance

  • Bashir Lawal,
  • Sung-Hui Tseng,
  • Janet Olayemi Olugbodi,
  • Sitthichai Iamsaard and ,
  • Omotayo B. Ilesanmi,
  • Mohamed H. Mahmoud,
  • Sahar H. Ahmed,
  • Gaber El-Saber Batiha and
  • Alexander T. H. Wu
  • + 4 authors+ 0 author

16 August 2021

Despite the advances in our understanding of the genetic and immunological basis of cancer, cancer remains a major public health burden with an ever-increasing incidence rate globally. Nevertheless, increasing evidence suggests that the components of...

(This article belongs to the Special Issue Genome Informatics and Cancers)
  • Article
  • Open Access
6 Citations
1,993 Views
21 Pages

Targeting the Kynureninase–HDAC6–Complement Axis as a Novel Therapeutic Strategy in Glioblastoma

  • Arif Ul Hasan,
  • Sachiko Sato,
  • Mami Obara,
  • Yukiko Kondo and
  • Eiichi Taira

Background/Objectives: Glioblastoma (GBM) is an aggressive brain tumor known for its profound heterogeneity and treatment resistance. Dysregulated complement signaling and epigenetic alterations have been implicated in GBM progression. This study ide...

  • Article
  • Open Access
8 Citations
3,257 Views
8 Pages

Safety and Efficacy of Eculizumab Therapy in Multiple Sclerosis: A Case Series

  • Marco Allinovi,
  • Angelo Bellinvia,
  • Francesco Pesce,
  • Sabrina Milan Manani and ,
  • Lorenzo Razzolini,
  • Brigida Brezzi,
  • Paolo Protopapa,
  • Vittorio Mantero,
  • Leonardo Caroti and
  • Lucia Del Vecchio
  • + 7 authors+ 2 authors

11 October 2021

(1) Background: Complement system activation has been proposed as one of the different factors that contribute to Multiple Sclerosis (MS) pathogenesis. In this study, we aimed to describe the potential effects of eculizumab, an anticomplement therapy...

(This article belongs to the Section Neuropharmacology and Neuropathology)
  • Review
  • Open Access
107 Citations
37,861 Views
19 Pages

New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy

  • Wilma Barcellini,
  • Anna Zaninoni,
  • Juri Alessandro Giannotta and
  • Bruno Fattizzo

27 November 2020

Autoimmune hemolytic anemia (AIHA) is a highly heterogeneous disease due to increased destruction of autologous erythrocytes by autoantibodies with or without complement involvement. Other pathogenic mechanisms include hyper-activation of cellular im...

(This article belongs to the Special Issue Diagnosis and Management of Autoimmune Hemolytic Anemias)
  • Review
  • Open Access
13 Citations
8,731 Views
23 Pages

Stargardt’s disease (STGD1) is an autosomal recessive juvenile macular degeneration caused by mutations in the ABCA4 gene, impairing clearance of toxic retinoid byproducts in the retinal pigment epithelium (RPE). This leads to lipofuscin accumu...

(This article belongs to the Special Issue Molecular Research in Retinal Degeneration)
  • Article
  • Open Access
1,553 Views
16 Pages

Association of Urinary Complement Peptides with Kidney Function and Progression of Kidney Disease

  • Thi Minh Nghia Nguyen,
  • Margarita Kondyli,
  • Harald Mischak,
  • Felix Keller and ,
  • Joachim Beige,
  • Agnieszka Latosinska and
  • Justyna Siwy
  • + 2 authors+ 0 author

19 February 2026

Complement activation has been implicated in many kidney diseases, but it remains unclear whether urinary complement-derived peptides reflect kidney function beyond albuminuria and predict disease progression. We analyzed mass spectrometry-based urin...

(This article belongs to the Special Issue 25th Anniversary of IJMS: Updates and Advances in Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
19 Citations
3,101 Views
14 Pages

AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer Patients

  • Po-Chao Hsu,
  • Tai-Kuang Chao,
  • Yu-Ching Chou,
  • Mu-Hsien Yu and ,
  • Yu-Chi Wang,
  • Yi-Hsin Lin,
  • Yi-Liang Lee,
  • Li-Chun Liu and
  • Cheng-Chang Chang
  • + 4 authors+ 0 author

30 September 2021

Antiangiogenic therapy, such as bevacizumab (BEV), has improved progression-free survival (PFS) and overall survival (OS) in high-risk patients with epithelial ovarian cancer (EOC) according to several clinical trials. Clinically, no reliable molecul...

(This article belongs to the Section Obstetrics & Gynecology)
  • Article
  • Open Access
15 Citations
1,360 Views
6 Pages

Treatment of Lewis lung carcinoma by photodynamic therapy and glucan from barley

  • Dalia Akramienė,
  • Gražina Graželienė,
  • Janina Didžiapetrienė and
  • Egidijus Kėvelaitis

Objective. During the photodynamic treatment, complement system is activated and tumor cells are opsonized with iC3b fragment. β-glucans can enhance cytotoxicity of iC3bopsonized cells due to their specific interaction with complement receptor 3 (CR3...

  • Review
  • Open Access
34 Citations
11,633 Views
20 Pages

12 March 2025

The antibody, linker, and payload moieties all play a significant role in giving the ADC its unique therapeutic potential. The antibody subclass employed in ADCs is determined based on relative individual receptor affinities and pharmacokinetics. Mea...

(This article belongs to the Section Cancer Drug Development)
  • Article
  • Open Access
12 Citations
5,543 Views
16 Pages

Genetic Variants of Complement Factor H Y402H (rs1061170), C2 R102G (rs2230199), and C3 E318D (rs9332739) and Response to Intravitreal Anti-VEGF Treatment in Patients with Exudative Age-Related Macular Degeneration

  • Agnieszka Kubicka-Trząska,
  • Katarzyna Żuber-Łaskawiec,
  • Sylwia Dziedzina,
  • Marek Sanak and ,
  • Bożena Romanowska-Dixon and
  • Izabella Karska-Basta
  • + 1 author+ 0 author

Background and Objectives: To assess the association between the single nucleotide polymorphisms (SNPs) in the genes encoding complement factors CFH, C2, and C3 (Y402H rs1061170, R102G rs2230199, and E318D rs9332739, respectively) and response to int...

(This article belongs to the Special Issue Modern Diagnostics and Therapy in Age-Related Macular Disease)
  • Review
  • Open Access
9 Citations
14,416 Views
26 Pages

How to Choose the Right Treatment for Membranous Nephropathy

  • Luigi Peritore,
  • Vincenzo Labbozzetta,
  • Veronica Maressa,
  • Chiara Casuscelli and ,
  • Giovanni Conti,
  • Guido Gembillo and
  • Domenico Santoro
  • + 2 authors+ 0 author

14 November 2023

Membranous nephropathy is an autoimmune disease affecting the glomeruli and is one of the most common causes of nephrotic syndrome. In the absence of any therapy, 35% of patients develop end-stage renal disease. The discovery of autoantibodies such a...

(This article belongs to the Section Urology & Nephrology)
  • Feature Paper
  • Review
  • Open Access
17 Citations
22,462 Views
21 Pages

Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy

  • Sigbjørn Berentsen,
  • Shirley D’Sa,
  • Ulla Randen,
  • Agnieszka Małecka and
  • Josephine M. I. Vos

20 September 2022

The last 2 decades have seen great progress in understanding the pathogenesis of cold agglutinin disease (CAD) and development of effective therapies. Cold agglutinins can cause hemolytic anemia as well as peripheral circulatory symptoms such as acro...

(This article belongs to the Special Issue Waldenström Macroglobulinaemia and Related Conditions)
  • Review
  • Open Access
333 Views
60 Pages

Immune Evasion Strategies of Human Poxviruses: A Roadmap for Engineering Low-Immunogenic CAR-Based and iPSC-Derived Cell Products

  • Daniil O. Antonov,
  • Marina Yu. Loguinova,
  • Hui Fan,
  • Elena V. Sazonova and ,
  • Anastasiia O. Sosnovtseva,
  • Dmitry S. Karpov,
  • Artem D. Molchanov,
  • Vladimir N. Nikolenko,
  • Vladimir P. Chekhonin and
  • Natalia G. Mokrysheva
  • + 5 authors+ 0 author

19 October 2026

Allogeneic chimeric antigen receptor (CAR)-based cell products and induced pluripotent stem cell (iPSC)-derived regenerative grafts increasingly use multilayer immune engineering. Current strategies are strongest against direct human leukocyte antige...

(This article belongs to the Special Issue Gene and Cell Therapy in Regenerative Medicine—Third Edition)
  • Review
  • Open Access
1 Citations
2,094 Views
25 Pages

Gene Therapy Advancements in Age-Related Macular Degeneration Treatment

  • Efstratia Amaxilati,
  • Eleftherios Chatzimichail,
  • Georgios N. Tsiropoulos,
  • Lorenzo Motta and ,
  • Theo Empeslidis,
  • Zisis Gatzioufas and
  • Georgios D. Panos
  • + 2 authors+ 0 author

21 February 2026

Age-related macular degeneration (AΜD) remains a leading cause of irreversible vision loss. Ιn neovascular AΜD (nAΜD), frequent intravitreal anti-VΕGF injections create substantial treatment burden, while approved therapies for...

  • Review
  • Open Access
387 Views
28 Pages

From Susceptibility Loci to Therapeutic Targets: The Genetic Architecture of IgA Nephropathy

  • Mikołaj Dopierała,
  • Nadja Nitz,
  • Jakub Bursy,
  • Antonina Garbowska and ,
  • Wiktoria Dopierała,
  • Krzysztof Schwermer and
  • Krzysztof Pawlaczyk
  • + 2 authors+ 0 author

2 October 2026

IgA nephropathy is the most common primary glomerulonephritis worldwide and a leading cause of chronic kidney disease and kidney failure in young and middle-aged adults, characterized by considerable ethnic differences in incidence and prognosis. Thi...

(This article belongs to the Special Issue Chronic Kidney Disease: Underlying Molecular Mechanisms—2nd Edition)
  • Review
  • Open Access
50 Citations
9,416 Views
21 Pages

14 October 2021

Primary IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and kidney failure for which there is no disease-specific treatment. However, this could change, since novel therapeutic approaches are currently being assessed in clinical t...

(This article belongs to the Special Issue New Insights into the Pathogenesis and Therapies of IgA Nephropathy)
  • Review
  • Open Access
409 Views
25 Pages

Antibody-Related Mechanisms in Ocular Diseases: Autoimmunity, Malignancy, and Therapeutic Targeting

  • Yehan Xiao,
  • Yaru Zou,
  • Mingming Yang,
  • Wendong Gu and ,
  • Zizhen Ye,
  • Jiaxin Deng,
  • Kyoko Ohno-Matsui and
  • Koju Kamoi
  • + 3 authors+ 0 author

8 October 2026

Antibodies in ocular disease have heterogeneous biological meanings: they may act as direct pathogenic effectors, systemic diagnostic biomarkers, indicators of B-cell clonality, or therapeutic agents. This distinction is particularly important in the...

(This article belongs to the Section Humoral Immunity)
  • Systematic Review
  • Open Access
668 Views
21 Pages

Background/Objectives: Glioblastoma (GBM) is the most common and lethal primary malignant brain tumor in adults, with a median survival of approximately 15 months despite maximal multimodal therapy. The complement system plays a paradoxical dual role...

(This article belongs to the Special Issue Glioblastoma: Molecular and Immune Pathology for the Development of Novel Therapies)
  • Review
  • Open Access
40 Citations
10,179 Views
13 Pages

Expanding the Role of Complement Therapies: The Case for Lupus Nephritis

  • Nicholas L. Li,
  • Daniel J. Birmingham and
  • Brad H. Rovin

7 February 2021

The complement system is an innate immune surveillance network that provides defense against microorganisms and clearance of immune complexes and cellular debris and bridges innate and adaptive immunity. In the context of autoimmune disease, activati...

(This article belongs to the Special Issue Clinical Advances in the Management of Glomerular Disease)
  • Review
  • Open Access
16 Citations
7,575 Views
26 Pages

Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging Therapies

  • Yuan Zong,
  • Miki Miyagaki,
  • Mingming Yang,
  • Jing Zhang and ,
  • Yaru Zou,
  • Kyoko Ohno-Matsui and
  • Koju Kamoi
  • + 2 authors+ 0 author

11 October 2024

Background: Monoclonal antibodies (mAbs) have demonstrated substantial potential in the treatment of intraocular diseases. This review aimed to comprehensively evaluate the applications, efficacy, and safety of mAbs in the management of intraocular c...

  • Review
  • Open Access
34 Citations
9,727 Views
29 Pages

Summary of the Therapeutic Options for Patients with Dry and Neovascular AMD

  • Dorota Śpiewak,
  • Łukasz Drzyzga,
  • Mariola Dorecka and
  • Dorota Wyględowska-Promieńska

19 July 2024

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness worldwide and a severe medical and social problem. The steadily increasing number of patients is related to the aging of the population. So far, many factors affect...

(This article belongs to the Special Issue Advances in the Diagnosis and Management of Age-Related Macular Degeneration)
  • Article
  • Open Access
13 Citations
4,773 Views
19 Pages

PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration

  • Sheri L. Peterson,
  • Anitha Krishnan,
  • Diyan Patel,
  • Ali Khanehzar and ,
  • Amit Lad,
  • Jutamas Shaughnessy,
  • Sanjay Ram,
  • David Callanan,
  • Derek Kunimoto and
  • Michael J. Tolentino
  • + 6 authors+ 1 author

17 April 2024

The alternative pathway of the complement system is implicated in the etiology of age-related macular degeneration (AMD). Complement depletion with pegcetacoplan and avacincaptad pegol are FDA-approved treatments for geographic atrophy in AMD that, w...

(This article belongs to the Section Pharmaceutical Technology)
  • Case Report
  • Open Access
1 Citations
3,180 Views
8 Pages

Continued Anticomplement Therapy: A Lifeline for Post-Renal-Transplant Patients with Complement-Mediated Hemolytic Uremic Syndrome

  • Natasha Venugopal,
  • Hyma V. Polimera,
  • Jessica Santucci,
  • Erik Washburn and
  • Elizabeth Federici

11 September 2024

Background: Complement-mediated hemolytic uremic syndrome (CM-HUS), formerly known as atypical HUS, is a rare but potentially fatal thrombotic microangiopathy (TMA) characterized by the triad of thrombocytopenia, microangiopathic hemolytic anemia (MA...

  • Article
  • Open Access
2 Citations
1,501 Views
15 Pages

Changes in Blood Cells and Complements During Relapse Prevention Therapies for Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder

  • Hiroshi Kuroda,
  • Kazuo Fujihara,
  • Kimihiko Kaneko,
  • Yoshiki Takai and ,
  • Yuki Matsumoto,
  • Mizuki Otomo,
  • Naoya Yamazaki,
  • Shu Umezawa,
  • Naoki Yamamoto and
  • Masashi Aoki
  • + 11 authors+ 6 authors

In this study, blood cell counts and serum C3, C4, and CH50 values at baseline and after more than 6-month drug use were measured to elucidate changes in blood cells and complements during relapse prevention therapies for aquaporin-4 antibody-positiv...

(This article belongs to the Special Issue Molecular Mechanism in Multiple Sclerosis and Related Disorders: 3rd Edition)
  • Article
  • Open Access
167 Views
28 Pages

rAAV-Mediated Dual Gene Therapy Targeting Oxidative Stress and Complement Activation in a Mouse Model of NaIO3-Induced Retinal Degeneration

  • Letong Liang,
  • Qinglinglan Zhou,
  • Bowen Chen,
  • Rui Yin and ,
  • Pingping Ding,
  • Yafei Tian,
  • Yang Zhang,
  • Mengru Li,
  • Jesse Luo and
  • Daru Lu
  • + 6 authors+ 1 author

6 November 2026

Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss worldwide, with dry AMD representing the predominant form of the disease, although effective treatments remain limited. The pathogenesis of dry AMD involves dysregu...

(This article belongs to the Section Health Outcomes of Antioxidants and Oxidative Stress)
  • Review
  • Open Access
30 Citations
8,562 Views
28 Pages

Associations between the Complement System and Choroidal Neovascularization in Wet Age-Related Macular Degeneration

  • Emilie Grarup Jensen,
  • Thomas Stax Jakobsen,
  • Steffen Thiel,
  • Anne Louise Askou and
  • Thomas J. Corydon

21 December 2020

Age-related macular degeneration (AMD) is the leading cause of blindness affecting the elderly in the Western world. The most severe form of AMD, wet AMD (wAMD), is characterized by choroidal neovascularization (CNV) and acute vision loss. The curren...

(This article belongs to the Special Issue Retinal Degeneration: From Pathophysiology to Therapeutic Approaches 2.0)
  • Article
  • Open Access
15 Citations
3,367 Views
17 Pages

Human Complement Inhibits Myophages against Pseudomonas aeruginosa

  • Julia E. Egido,
  • Simon O. Dekker,
  • Catherine Toner-Bartelds,
  • Cédric Lood and ,
  • Suzan H. M. Rooijakkers,
  • Bart W. Bardoel and
  • Pieter-Jan Haas
  • + 2 authors+ 0 author

3 November 2023

Therapeutic bacteriophages (phages) are primarily chosen based on their in vitro bacteriolytic activity. Although anti-phage antibodies are known to inhibit phage infection, the influence of other immune system components is less well known. An impor...

(This article belongs to the Special Issue Viruses versus Bacteria—Novel Approaches to Phage Therapy as a Tool against Multidrug-Resistant Pathogens)
  • Article
  • Open Access
6 Citations
3,988 Views
20 Pages

Dysregulation of Immune Cell Subpopulations in Atypical Hemolytic Uremic Syndrome

  • I-Ru Chen,
  • Chiu-Ching Huang,
  • Siang-Jyun Tu,
  • Guei-Jane Wang and ,
  • Ping-Chin Lai,
  • Ya-Ting Lee,
  • Ju-Chen Yen,
  • Ya-Sian Chang and
  • Jan-Gowth Chang
  • + 4 authors+ 0 author

Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening thrombotic microangiopathy. Definitive biomarkers for disease diagnosis and activity remain elusive, making the exploration of molecular markers paramount. We conducted single-cell...

(This article belongs to the Section Molecular Immunology)
  • Review
  • Open Access
86 Citations
6,450 Views
20 Pages

Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma

  • Francesco Lasorsa,
  • Monica Rutigliano,
  • Martina Milella,
  • Matteo Ferro and ,
  • Savio Domenico Pandolfo,
  • Felice Crocetto,
  • Simona Simone,
  • Loreto Gesualdo,
  • Michele Battaglia and
  • Giuseppe Lucarelli
  • + 6 authors+ 1 author

20 November 2023

The crosstalk among the complement system, immune cells, and mediators of inflammation provides an efficient mechanism to protect the organism against infections and support the repair of damaged tissues. Alterations in this complex machinery play a...

(This article belongs to the Section Biochemistry)
  • Review
  • Open Access
15 Citations
8,883 Views
30 Pages

The Complement System as a Therapeutic Target in Retinal Disease

  • Joshua Ong,
  • Arman Zarnegar,
  • Amrish Selvam,
  • Matthew Driban and
  • Jay Chhablani

The complement cascade is a vital system in the human body’s defense against pathogens. During the natural aging process, it has been observed that this system is imperative for ensuring the integrity and homeostasis of the retina. While this s...

(This article belongs to the Special Issue Retinal Diseases: Clinical Presentation and Novel Treatments)
  • Review
  • Open Access
1 Citations
994 Views
21 Pages

Mesenchymal stromal cells are increasingly used for their immunomodulatory and regenerative properties, yet their interaction with the hemostatic system remains incompletely understood. This review examines the mechanisms through which these cells in...

(This article belongs to the Special Issue Novel Dynamics and Mechanisms of Stromal–Leukocyte Interactions in Tissue Inflammation, Immunity and Healing)

of 28